Archives

  • Volume 2, Issue 1, Spring 2025

    • Capillaroscopy in Systemic Autoimmune Rheumatic Diseases: A Clinical Tool Linking Diagnosis and Pathogenesis 
    • Glucagon-like-peptide 1 (GLP-1) Receptor Agonists in Rheumatologic Disease
    • The Past, Present and Future of Antinuclear Antibody (ANA) Testing 
    • The Impact of Chimeric Antigen Receptor (CAR) T Cell Therapy: Its Potential to Reshape Rheumatology Practice
    • Imaging for Diagnosis and Differential Diagnosis of Axial Spondyloarthritis

  • Volume 1, Issue 3, Fall 2024

    • Echoes of Change: How Ultrasound Has Transformed Giant Cell Arteritis Detection
    • Contemporary Management of Raynaud’s Phenomenon
    • The 2023 ACR/EULAR Classification Criteria for Antiphospholipid Syndrome: Implications for the Inclusion of Participants in Research vs Diagnosis in Clinical Practice
    • An Update on the Benefits and Safety Profile of Hydroxychloroquine

  • Volume 1, Issue 2, Summer 2024

    • Shifting Paradigms in the Treatment of Systemic Lupus Erythematosus
    • Exploring Newer Topical Therapies for Inflammatory Skin Diseases: A Guide for Rheumatologists 
    • Osteoporosis in 2024: Frequency, Monitoring and Treatment
    • Screening and Management of Atherosclerotic Cardiovascular Disease in Inflammatory Arthritis: A Comprehensive Approach for the Rheumatologist
    • Axial Spondyloarthritis Treatment Recommendations in 2024: Where Are We Now?

  • Volume 1, Issue 1, Spring 2024

    • Update on Lupus Nephritis
    • Sjogren’s Syndrome: Strategies for Treatment
    • Updates in Treatment of Refractory Inflammatory Myositis
    • What the Rheumatologist Needs to Know About IBD Treatment
    • Management of Rheumatologic Immune-related Adverse Events (RRh-irAEs) – An Overview of Immunosuppressive Therapies